MYCN and neoplasm: Using the set of 72 significant genes for a hierarchical clustering of MYCN amplified stage 3 or 4 tumours and MYCN non-amplified tumours with stages 1, 2, 4s, both prognosis groups are clearly separated (Fig. 2).